Rituximab tratamiento de la artritis reumatoide refractaria.

Autores
Categoría Resumen estructurado de revisiones sistemáticas
RevistaDatabase of Abstracts of Reviews of Effects (DARE)
Año 2009
Cargando información sobre las referencias

CRD SUMMARY:

This review assessed the effectiveness and safety of rituximab in the treatment of refractory rheumatoid arthritis. The authors concluded that rituximab, when administered with cyclophosphamide or methotrexate, appears to be an acceptable treatment. Based on the evidence presented and the review methodology, the authors' conclusions should be interpreted with care. However, recommendations for further research are appropriate.
Epistemonikos ID: f1fed08b63737074e08391d80ede9e32574ed4e0
First added on: Jun 08, 2012